PDIA3 and cancer: The GSEA result suggests that PDIA3 is closely associated with immune-activated processes, such as TNFA-signaling-via-NFKB, IFN-α response, IFN-γ response, inflammatory-response, and allograft-rejection pathways, but completely opposite results were observed in distinct cancer types.